You are subscribed to one or more CDC code set email subscription services. Subscription links are available on each of the pages below.
Vaccine Code Set Update Publication Date: January 25, 2022
The individual filenames included in this distribution contain the publication date (20220125)
Release Notes: This release includes updates for all vaccine codes except core Vaccine Information Statement (VIS) codes. This release does include one update to the CVX to VIS map.
Release notes are designed as a guide to highlight changes that have been made to the vaccine codes since the last publication. They should not be used as the primary source of code information. The vaccine code files themselves should be utilized.
General Note Regarding This Release: Codes with “Last Update” dates from December 13, 2021 to January 25, 2022 reflect the changes and additions in this release. This release includes the following code set updates:
Vaccine Code Set Updates Not Related to COVID-19
- New Hepatitis B Vaccine
- Retired NDCs from FDA files at year end and retired Southern Hemisphere Seasonal Influenza vaccine NDCs
COVID-19 Related Code Updates- Retired NDC Units of Sale – will not be produced in these carton sizes
- Minor Code Description or Note Updates
Vaccine Code Set Updates Not Related to COVID-19- New Hepatitis B Vaccine:
New CDC Codes and Maps | New NDC Codes |
|---|
- New Product Table Tradename: “PREHEVBRIO Hepatitis B Vaccine (Recombinant)”
- New MVX Code: VBI “VBI Vaccines, Inc”
- New CVX Code: 220 “Hepatitis B vaccine (recombinant), Al(OH)3 adjuvanted”
- CVX 220 associated to Vaccine Group: HepB
- CPT to CVX Map: CPT Code 90759 “Hepatitis B vaccine (HepB), 3-antigen (S, Pre-S1, Pre-S2), 10 mcg dosage, 3 dose schedule, for intramuscular use” mapped to CVX code 220
- CVX to VIS Map: CVX Code mapped to existing VIS barcode string = 253088698300005911211015 for current “Hepatitis B Vaccine VIS”
| NDC Unit of Sale: - NDC10 = 75052-001-10
- NDC11 = 75052-0001-10
NDC Unit of Use: - NDC10 = 75052-001-01
- NDC11 = 75052-0001-01
|
|---|
- NDCs retired effective 12/31/2021: Table 2 below identifies the retired NDC code pairs in this code release.
Table 2: NDC Pairs Retired
Sale Proprietary Name | Sale Labeler | Unit of Sale NDC11 | Unit of Use NDC11 |
|---|
Bexsero | GlaxoSmithKline Biologicals SA | 58160-0976-06 | 58160-0976-02 |
|---|
PedvaxHIB | Merck Sharp & Dohme Corp. | 00006-4897-00 | 00006-4897-01 |
|---|
RECOMBIVAX HB | Merck Sharp & Dohme Corp. | 00006-4981-00 | 00006-4981-01 |
|---|
RECOMBIVAX HB | Merck Sharp & Dohme Corp. | 00006-4995-41 | 00006-4995-01 |
|---|
RECOMBIVAX HB | Merck Sharp & Dohme Corp. | 00006-4094-02 | 00006-4094-01 |
|---|
RECOMBIVAX HB | Merck Sharp & Dohme Corp. | 00006-4995-00 | 00006-4995-01 |
|---|
RECOMBIVAX HB | Merck Sharp & Dohme Corp. | 00006-4094-09 | 00006-4094-01 |
|---|
RECOMBIVAX HB | Merck Sharp & Dohme Corp. | 00006-4093-09 | 00006-4093-01 |
|---|
RECOMBIVAX HB | Merck Sharp & Dohme Corp. | 00006-4992-00 | 00006-4992-01 |
|---|
RECOMBIVAX HB | Merck Sharp & Dohme Corp. | 00006-4093-02 | 00006-4093-01 |
|---|
VAQTA | Merck Sharp & Dohme Corp. | 00006-4095-02 | 00006-4095-01 |
|---|
VAQTA | Merck Sharp & Dohme Corp. | 00006-4841-41 | 00006-4841-01 |
|---|
VAQTA | Merck Sharp & Dohme Corp. | 00006-4841-00 | 00006-4841-01 |
|---|
VAQTA | Merck Sharp & Dohme Corp. | 00006-4096-02 | 00006-4096-01 |
|---|
VAQTA | Merck Sharp & Dohme Corp. | 00006-4831-41 | 00006-4831-01 |
|---|
FLUZONE QUADRIVALENT SOUTHERN HEMISPHERE | Sanofi Pasteur Inc. | 49281-0182-25 | 49281-0182-00 |
|---|
FLUZONE QUADRIVALENT SOUTHERN HEMISPHERE | Sanofi Pasteur Inc. | 49281-0321-50 | 49281-0321-88 |
|---|
FLUZONE QUADRIVALENT SOUTHERN HEMISPHERE | Sanofi Pasteur Inc. | 49281-0337-15 | 49281-0337-78 |
|---|
COVID-19 Related Code Updates
- Retired NDC Units of Sale
Table 3: Retired Unit of Sale COVID-19 NDC Codes:
NDC Unit of Sale Codes Retired. Vaccines will not be manufactured in these package sizes. |
|---|
COVID-19 Vaccine | CVX Code | Unit of Sale NDC | Retired Carton Size |
|---|
Pfizer-BioNTech COVID-19 Vaccine | 217 | 59267-1025-2 | 195 multi-dose vials |
|---|
Pfizer-BioNTech COVID-19 Vaccine | 218 | 59267-1055-2 | 195 multi-dose vials |
|---|
Pfizer-BioNTech COVID-19 Vaccine | 219 | 59267-0078-2 | 195 multi-dose vials |
|---|
- Minor Code Description or Note Updates
- CVX Code 219 “SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 3 mcg/0.2mL dose, tris-sucrose formulation”. No code or description changes, CVX notes field updated to reflect anticipated age range to be included in potential FDA EUA submission for this vaccine.
